Immunotherapy can backfire when a supercharged immune system attacks healthy cells, but researchers are hopeful for the future.
Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.
Designer antibodies, such as checkpoint inhibitors, have revolutionized cancer treatment.
Ways to Give
Find a Physician
The company targets accelerated diagnosis and treatment of cancer by providing optimal tissue samples for effective personalized medicine.